Wells Fargo analyst Colin Langan maintains Visteon (NASDAQ:VC) with a Underweight and raises the price target from $101 to $103.
August 10, 4:49 PM
Akerna (NASDAQ:KERN) reported quarterly sales of $6.10 million which missed the analyst consensus estimate of $7.04 million by 13.35 percent. This is a 48.38 percent increase over sales of $4.11 million the same period
July 3, 6:26 AM
Moderna Inc (NASDAQ: MRNA) submitted a regulatory application to the European Medicines Agency (EMA) for its updated COVID-19 vaccine encoding the spike protein for the XBB.1.5
February 13, 11:07 AM
Forian Inc. (NASDAQ: FORA) announced the sale of its cannabis software subsidiary, Bio-Tech Medical Software, Inc. (d/b/a BioTrack), to Alleaves, Inc., effective February 10, 2023, for a total purchase price of $30